Abstract:Objective:To evaluate the effects of topiramate(TPM) and sodium valproate retard tablet(VAP) on cognitive function in adult patients with epilepsy.Methods:Sixty-two adult patients,newly diagnosed as epilepsy,were randomly divided into 2 groups:TPM Group(n = 30) and VAP Group(n = 32).The cognitive function of all the patients in these two groups were evaluated by the Revised Adult Wechsler memory scale(WMS-RC) and event related potentials(ERPs) before treatment and after two months admin-istration of TPM / VAP.Results:①Before administration of TPM:Memory Quotient(MQ) 100,accounting for 26.67%;In the ERPs,the P3 wave latency 359.9ms,accounting for 33.33%.Before administration of VAP:MQ 100,accounting for 28.0%;In the ERPs,the P3 wave latency 359.9ms,accounting for 31.25%.There was not significant difference between these two groups with respect to the cognitive function(P 0.05).②After administration of TPM,in TPM Group the score of sequence counts of 1 to 100 declined(P 0.01),the score of sequence counts of 100 to1 declined(P 0.05),the score of digit cumulate cognitive function declined(P 0.05),the mistakes of cards recognition increased(P 0.01),the function of cards remembrance declined(P 0.01),the mistakes of cards reclamation increased(P 0.01),the mistakes of word association increased(P 0.01),the object touch was more difficult(P 0.01),the function of story apprehension declined(P 0.01)and the natural order and anti-natural order repeat of digit were more difficult(P 0.01).In the ERPs,the N1 wave latency prolonged(P 0.05) and the P2,N2 and P3 waves latencies all prolonged significantly(P 0.01),while the amplitude of P3 wave declined(P 0.01).After administration of VAP,in VAP Group:the score of WMS-RC TEST in every item did not change significantly(P 0.05).In the ERPs,the N1 wave latency shortened(P 0.05) and the P2,N2 and P3 waves latencies all shortened significantly(P 0.01),while the amplitude of P3 wave did not increase significantly(P 0.05).③The transient memory of WMS-RC was reversely correlated with the P3 wave latency(P 0.05).Conclusion:After administrateration of TPM,patients with epilepsy who were in the drug titration phase were more likely to suffer from many cognitive disturbers;Patients’ cognitions were improved by administration of VAP;After examination of ERPs and WMS-RC,the results of evalua-tion of cognitive function will be more objective and comprehensive.

Efficiency and safety of topiramate in treatment of adults with epilepsy

Therapeutic effect of topiramate as adjunctive therapy in adults with refractory partial epilepsy

Topiramate as used for treating 104 cases of epilepsy in children

A compared study of treating Tourette′s syndrome with topiramate

Long-term Efficacy Observation of Topiramate in Treatment of Epilepsy

Outcomes Of Sustained-Release Formulation Of Valproate And Topiramate Monotherapy In Patients With Epilepsy: A Multi-Centre, Cohort Study

PO10.1 the Effects of Topiramate and Sodium Valproate Retard Tablet on Cognitive Function in Adult with Epilepsy

Evaluation of Immune Function Enhancement and Clinical Symptom Alleviation in Epilepsy Patients Post-Topiramate Administration

Evaluation of Open-Label Topiramate As Primary or Adjunctive Therapy in Infantile Spasms

Effects of Topiramate on Weight and Metabolism in Children with Epilepsy

The Retention Rate of Treatment and Long-term Tolerability of the New Type of Antiepileptic Drugs

Clinical Efficacy of New Antiepileptic Drugs in Refractory Partial Epilepsy: Experience in the United States With Three Novel Drugs

The effects of topiramate on cognitive function and NCAM expression in hippocampus of epilepsy rats

Effect of Lamotrigine on Quality of Life in Patients with Newly Diagnosed Epilepsy

Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis

Effects of topiramate on seizure susceptibility in kainate-kindled rats: involvement of peripheral-type benzodiazepine receptors.

Effects of Different Doses of Topiramate on Expression of NCAM and GAP- 43 Mrna in Hippocampus of Rats with Epilepsy

Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis

Revisiting the Efficacy and Tolerability of Topiramate for Tic Disorders: A Meta-Analysis.

Topiramate ban in women of childbearing potential with idiopathic generalized epilepsy: Does effectiveness offset the teratogenic risks?

Therapeutic Effects of Carbamazepine Plus Valproate on Intractable Partial Epilepsy